EAM
BIIB icon

Eagle Asset Management’s Biogen BIIB Stock Holding History

Eagle Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,942
Closed -$1.56M – 567
2020
Q1 		$1.56M Sell
4,942
-156
-3% -$47.3K 0.01% 486
2019
Q4 		$1.51M Sell
5,098
-5,279
-51% -$1.46M 0.01% 532
2019
Q3 		$2.42M Buy
+10,377
New +$2.42M 0.01% 493
2019
Q1 		– Sell
-719
Closed -$216K – 611
2018
Q4 		$216K Buy
719
+131
+22% +$41.8K ﹤0.01% 592
2018
Q3 		$207K Buy
+588
New +$202K ﹤0.01% 603
2017
Q2 		– Sell
-3,459
Closed -$945K – 638
2017
Q1 		$945K Sell
3,459
-3,459
-50% -$978K 0.01% 596
2016
Q4 		$1.96M Buy
6,918
+33
+0.5% +$9.78K 0.01% 549
2016
Q3 		$2.15M Buy
+6,885
New +$2.04M 0.01% 543

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eagle Asset Management's BIIB Position: Q2 2020 in Review

Eagle Asset Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 4,942 shares — an estimated $1.56M sold.

Eagle Asset Management first reported a position in BIIB in Q3 2016 and held it in 8 quarters. The position peaked at $2.42M in Q3 2019. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Eagle Asset Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Eagle Asset Management sold 4,942 Biogen shares in Q2 2020, an estimated $1.56M.
  • Eagle Asset Management first reported a position in Biogen in Q3 2016 and held it in 8 quarters.
  • Eagle Asset Management's Biogen position peaked at $2.42M in Q3 2019.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Eagle Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.